病例报告:由慢性淋巴细胞白血病引起的脏全移植透,已成功用尚布鲁丁尼布治疗

Brian Abboud1, Nehemias Guevara Rodriguez2, Arslan Babar2

  • 1Department of Internal Medicine, SSM Health-Saint Louis University School of Medicine, Saint Louis, MO, United States.

Frontiers in oncology
|February 18, 2026
PubMed
概括

慢性淋巴细胞白血病 (CLL) 很少影响移植. 一名在移植脏中透了CLL的患者在接受Zanubrutinib治疗后,表现出改善的功能,这是一种布鲁顿氨酸激酶抑制剂.